Lv2
168 积分 2026-03-11 加入
Incidence and risk factors of immune checkpoint inhibitor myocardial and muscle toxicity: a French nationwide study
10天前
已完结
Clinical prevalence and outcome of cardiovascular events in the first 100 days postallogeneic hematopoietic stem cell transplant
10天前
已完结
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
10天前
已完结
Cardiovascular Safety of Carfilzomib in Patients with Multiple Myeloma
10天前
已完结
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma
12天前
已完结
Cardiac events during treatment with proteasome inhibitor therapy for multiple myeloma
12天前
已完结
Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma
12天前
已完结
Cyclophosphamide-induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less
12天前
已完结
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial
12天前
已完结
Cardiac safety of lapatinib: pooled analysis of 3689 patients enrolled in clinical trials
12天前
已完结
皖公网安备34019202002308
